Last Price
73.50
Today's Change
-0.70 (0.94%)
Day's Change
72.81 - 74.36
Trading Volume
292,217
Market Cap
13 Billion
Shares Outstanding
178 Million
Avg Volume
1,512,755
Avg Price (50 Days)
72.33
Avg Price (200 Days)
57.27
PE Ratio
-13.24
EPS
-5.55
Earnings Announcement
20-Feb-2025
Previous Close
74.20
Open
73.50
Day's Range
72.81 - 74.36
Year Range
21.92 - 80.53
Trading Volume
292,289
1 Day Change
-0.94%
5 Day Change
-2.44%
1 Month Change
4.79%
3 Month Change
-0.55%
6 Month Change
19.22%
Ytd Change
145.49%
1 Year Change
162.59%
3 Year Change
172.73%
5 Year Change
217.63%
10 Year Change
420.17%
Max Change
-55.45%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.